St Jude Medical Inc. (STJ)

STJ (NYSE:Health Services)
$62.49
pos +0.00
+0.00%
Today's Range: 60.93 - 62.64 | STJ Avg Daily Volume: 2,232,200
Last Update: 04/17/14 - 4:00 PM EDT
Volume: 0
YTD Performance: 0.87%
Open: $0.00
Previous Close: $62.04
52 Week Range: $40.31 - $68.79
Oustanding Shares: 283,804,872
Market Cap: 17,741,109,593
6-Month Chart
TheStreet Ratings Grade for STJ
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 13 13 13 11
Moderate Buy 1 0 0 0
Hold 6 7 7 10
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 1.79 1.86 1.86 2.09
Latest Dividend: 0.27
Latest Dividend Yield: 1.61%
Dividend Ex-Date: 03/27/14
Price Earnings Ratio: 17.89
Price Earnings Comparisons:
STJ Sector Avg. S&P 500
17.89 24.30 29.08
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-5.17% 49.46% 17.99%
GROWTH 12 Mo 3 Yr CAGR
Revenue 0.00 0.07 0.02
Net Income -8.00 -0.24 -0.09
EPS 4.20 -0.09 -0.03
Earnings for STJ:
EBITDA 1.65B
Revenue 5.50B
Average Earnings Estimates
Qtr (06/14) Qtr (09/14) FY (12/14) FY (12/15)
Average Estimate $1.00 $0.96 $3.98 $4.32
Number of Analysts 12 13 15 14
High Estimate $1.02 $0.99 $4.00 $4.42
Low Estimate $0.99 $0.93 $3.95 $4.24
Prior Year $0.96 $0.90 $3.76 $3.98
Growth Rate (Year over Year) 4.43% 6.24% 5.90% 8.60%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Bullish
Feb 10, 2014 | 7:51 AM EST
STJ was upgraded to Outperform, William Blair said. New product portfolio should drive growth in the coming quarters. 
Bullish
Feb 10, 2014 | 7:18 AM EST
STJ was upgraded from Hold to Buy, Stifel Nicolaus said. $75 price target. Company can show accelerating sales growth and expanding mar...
Update
Feb 07, 2014 | 7:19 AM EST
STJ - St. Jude Medical, Inc. 2014 Investor Meeting - 8AM 
Bullish
Jan 06, 2014 | 8:22 AM EST
STJ was upgraded from Equal-weight to Overweight, Morgan Stanley said. $75 price target. Organic growth is accelerating. 
Update
Dec 16, 2013 | 8:08 AM EST
STJ was upgraded to Outperform from Marketperform, BMO said. Benefits from improving ICD market, FDA approval of CardioMEMS, and new pr...

Off the Charts Real Money Pro($)

Maintain a stock-specific approach until a clearer trend develops.
Bullish
Aug 09, 2013 | 8:25 AM EDT
STJ was upgraded from Market Perform to Outperform, Wells Fargo said. CardioMEMS will likely receive U.S. approval and the stock is the...
Bullish
Jul 18, 2013 | 8:12 AM EDT
Shares of STJ now seen reaching $52, according to BMO Capital Markets. Estimates also upped, given the company's new guidance. Market P...

Early-Morning Market Look Real Money Pro($)

Let's take a peek at overnight and early-morning price action in the major asset classes.
Bearish
May 28, 2013 | 7:55 AM EDT
STJ was downgraded from Hold to Sell, Canaccord Genuity said. $35 price target. Earnings quality is declining and the company is facing...

Columnist Conversations

The new Fed Chief said this at a recent meeting of the Economic Club of NY ... "We have indeed had a disappoin...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.